Aztreonam for Inhalation Solution (AZLI)

DRUG2 trials

Sponsors

Gilead Sciences

Conditions

Cystic Fibrosis

Phase 2

Aztreonam Lysine for Pseudomonas Infection Eradication Study

CompletedNCT01375049

Gilead SciencesCystic Fibrosis

Start: 2011-08-31End: 2013-05-31Updated: 2014-07-17

Phase 3

Aztreonam for Inhalation Solution vs Tobramycin Inhalation Solution in Patients With Cystic Fibrosis & Pseudomonas Aeruginosa

CompletedNCT00757237

Gilead SciencesCystic Fibrosis

Start: 2008-08-31End: 2010-11-30Updated: 2011-07-04

Related Papers

Open label study of inhaled aztreonam for Pseudomonas eradication in children with cystic fibrosis: The ALPINE study.

2014-08-0138 citations

Inhaled aztreonam lysine vs. inhaled tobramycin in cystic fibrosis: a comparative efficacy trial.

2012-09-1593 citations